China Life Insurance : announces the resolution of Investment Management Committee to acquire CDIB Capital II Healthcare Ventures Limited Partnership

Close

Today's Information

Provided by: China Life Insurance Co., Ltd.
SEQ_NO	1	Date of announcement	2021/12/20	Time of announcement	22:00:32
Subject	China Life Insurance Co., Ltd. announces the resolution of Investment Management Committee to acquire CDIB Capital II Healthcare Ventures Limited Partnership
Date of events	2021/12/20	To which item it meets	paragraph 24
Statement	1.Name and nature of the underlying security (if preferred shares, the terms and conditions of issuance shall also be indicated, e.g., dividend yield): CDIB Capital II Healthcare Ventures Limited Partnership�FVenture investment projects 2.Date of occurrence of the event:2021/12/20 3.No., unit price, and monetary amount of the transaction: No.: NA Unit price: NA Total Price: NTD 330,681,302 4.Counterparty to the trade and its relationship to the company (if the trading counterparty is a natural person and not a related party of the company, its name is not required to be disclosed): Counterparty: CDIB Venture Capital Corporation Relationship: Related party 5.Where the counterparty to the trade is a related party, an announcement shall also be made of the reason for choosing the related party as trading counterparty and the identity of the previous owner, including its relationship with the company and the trading counterparty, the price of the ownership transfer, and date of transfer: Because of the great potential of biomedical sector, the company decide to invest. The counterparty of the transaction is the original investor, and there is no previous transfer. 6.Where the owner of the underlying securities within the past five years has been a related party of the company, an announcement shall also include the dates and prices of acquisition and disposal by the related party and its relationship with the company at the time: CDIB Venture Capital Corporation promised to invest in CDIB Capital II Healthcare Ventures Limited Partnership in 2020. The commitment of NTD 153,095,427 has been paid,and the committed amount of NTD 196,904,573 has not been invested yet. A total of NTD 350,000,000 will be transferred to the company . 7.Matters related to the creditor��s rights currently being disposed of (including type of collateral of the disposed creditor��s rights; if the creditor��s rights are creditor��s rights over a related party, the name of the related party and the book amount of such creditor��s rights currently being disposed of must also be announced): N/A 8.Profit (or loss) from the disposal (not applicable in cases of acquisition of securities) (where originally deferred, the status or recognition shall be stated and explained): N/A 9.Terms of delivery or payment (including payment period and monetary amount), restrictive covenants in the contract, and other important stipulations: After approved by government, will pay NTD 133,776,729 to CDIB Venture Capital Corporation . The rest amount of NTD 196,904,573, will be paid to CDIB Capital II Healthcare Ventures Limited Partnership by call notices after approved by government. 10.The manner in which the current transaction was decided, the reference basis for the decision on price, and the decision-making unit: According to KPMG Valuation Report and CPA Fair Value Report. The decision-making is following the authorization procedure of the company 11.Net worth per share of company of the underlying securities acquired or disposed of: N/A 12.The discrepancy between the reference price of private placement company and the transaction amount per share is 20 percent or more: N/A 13.Current cumulative no., amount, and shareholding ratio of the securities being traded (including the current transaction) as of the date of occurrence and status of any restriction of rights (e.g.,pledges): Current cumulative no.: N/A (due to the nature of Venture Capital Fund) Amount: The company promised to invest NTD 300,000,000 in CDIB Capital II Healthcare Ventures Limited Partnership in 2020, Add to this transaction NTD 330,681,302 , totaling NTD 630,681,302 Percentage: 20.9%, calculated by committed investment amount Restriction of right: None 14.Privately placed securities (including the current transaction) as a percentage of total assets of the company and shareholder��s equity of the parent company on the latest financial statements, and the operating capital on the latest financial statements as of the date of occurrence: ratio of private placement of securities to the total assets:0.98% ratio of private placement of securities to shareholder's equity:13.43% operating capital as shown in the most recent financial statement:N/A 15.Broker and broker's fee: N/A 16.Concrete purpose or use of the acquisition or disposition: In compliance with Insurance Law, legal use of the insurance funds 17.Whether the directors expressed any objection to the present transaction: N/A 18.Whether the trading counterparty is a related party: Yes 19.Date of approval by board of directors: Will be on 2021/12/23 20.Recognition date by supervisors or approval date by audit committee: N/A 21.Whether the CPA issued an opinion on the unreasonableness of the current transaction: No 22.Name of the CPA firm:Favorable Business Partner CPAs 23.Name of the CPA:DAI,CAI-YONG 24.License no.of the CPA:Taipei Certified Public Accountants No.3904 25.Any other matters that need to be specified: None